Evidence map›Paper›PMID 29091975›Full record

ArticleJournal of hospital medicine2017

Treatment Trends and Outcomes in Healthcare-Associated Pneumonia.

Sarah Haessler, Tara Lagu, Peter K Lindenauer, Daniel J Skiest, Aruna Priya, Penelope S Pekow, Marya D Zilberberg, Thomas L Higgins, Michael B Rothberg

Open access · bronzeAbstract read
In one paragraph

Article in Journal of hospital medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Treatment and outcomes among patients ≥85 years hospitalized with community-acquired pneumonia.Journal of investigative medicine : the official publication of the American Federation for Clinical Research · 2022
    Article
  3. Pneumococcal Urinary Antigen Testing in United States Hospitals: A Missed Opportunity for Antimicrobial Stewardship.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Sarah HaesslerDivision of Infectious Diseases, Baystate Medical Center, Springfield, Massachusetts, USA. Sarah.Haessler@baystatehealth.org.
Tara LaguTufts University School of Medicine, Boston, Massachusetts, USA.
Peter K LindenauerTufts University School of Medicine, Boston, Massachusetts, USA.
Daniel J SkiestDivision of Infectious Diseases, Baystate Medical Center, Springfield, Massachusetts, USA.
Aruna PriyaCenter for Quality of Care Research, Baystate Medical Center, Springfield, Massachusetts, USA.
Penelope S PekowCenter for Quality of Care Research, Baystate Medical Center, Springfield, Massachusetts, USA.
Marya D ZilberbergEviMed Research Group, LLC, Goshen, Massachusetts, USA.
Thomas L HigginsTufts University School of Medicine, Boston, Massachusetts, USA.
Michael B RothbergDepartment of Medicine, Medicine Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Baystate Medical Center · USTufts University · USCleveland Clinic · USUniversity of Massachusetts Amherst · US

Funding

Quality of Care and Outcomes of Healthcare-Associated PneumoniaR01HS018723 · AHRQ · BAYSTATE MEDICAL CENTER, INC. · PI LINDENAUER, PETER KYLE · 2010 to 2012
$1.1M
Defining Optimal Clinical Strategies for Critically Ill Heart Failure PatientsK01HL114745 · NHLBI · BAYSTATE MEDICAL CENTER, INC. · PI LAGU, TARA C · 2013 to 2017
$721k
Research and Mentoring in Comparative Effectiveness and Implementation ScienceK24HL132008 · NHLBI · BAYSTATE MEDICAL CENTER, INC. · PI LINDENAUER, PETER KYLE · 2016 to 2020
$574k
AHRQ HHS R01 HS018723NHLBI NIH HHS K01 HL114745NHLBI NIH HHS K24 HL132008
6 · The paper itself

Abstract

backgroundThe American Thoracic Society and Infectious Diseases Society of America guidelines for management of healthcare-associated pneumonia (HCAP), first published in 2005, have been controversial regarding the selection of empiric broad-spectrum antibiotics, whether the criteria for HCAP predicts the likelihood of infection with multidrug resistant organisms, and whether HCAP patients have improved outcomes when treated with empiric broad-spectrum antibiotics.

methodsA retrospective cohort study at 488 US hospitals from July 2007 to November 2011. Patients who met criteria for HCAP were included. Guideline-concordant antibiotics were assessed based on guideline recommendations. We assessed changes in hospital rates of concordant antibiotic use over time and their correlation with outcomes.

resultsAmong 149,963 patients with HCAP, 19.6% received fully guideline-concordant antibiotics, 21.7% received partially concordant antibiotics, and 58.9% received discordant antibiotics. Guideline concordance increased over time. Rates of fully or partially concordant antibiotics varied across hospitals (median 36.4%; interquartile range 25.8%-49.1%). Among patients who received discordant antibiotics, 81.5% were treated according to community-acquired pneumonia (CAP) guidelines. On average, the rate of guideline concordance increased by 2.2% per 6-month interval, while hospital level rates of mortality, excess length of stay, and progression to respiratory failure did not change.

conclusionsIn this large, nationally representative cohort, only 1 in 5 patients with risk factors for HCAP received treatment that was fully in accordance with guidelines, and many received CAP therapy instead. At the hospital level, increases in the use of concordant antibiotics were not associated with declines in mortality, excess length of stay, or progression to respiratory failure.

Indexed as

AgedAnti-Bacterial AgentsCommunity-Acquired InfectionsCross InfectionFemaleGuideline AdherenceHumansLength of StayMalePneumonia, BacterialRetrospective StudiesRisk FactorsTreatment OutcomeUnited StatesAnti-Bacterial Agents

Identifiers

PMID29091975
PMCPMC6005651
OpenAlexW2766564703

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.